<unk>  <unk>  is a neurodevelopmental disorder characterized by excessive amounts of inattention, carelessness,<unk>  (which evolves into inner restlessness in adulthood), and impulsivity that are pervasive, impairing, and otherwise age-inappropriate. Some individuals with<unk>  also display difficulty regulating emotions and suffer from executive dysfunction. For a diagnosis, the symptoms have to cause problems in at least two settings (such as school, home, work, or leisure time) for over six months. In children, problems paying attention may result in poor school performance.<unk>  is also associated with other mental disorders and substance use disorders, which can cause additional impairment, especially in modern society. Although people with<unk>  struggle to focus on tasks they are not particularly interested in completing, they are often able to maintain an unusually prolonged and intense level of attention for tasks they do find interesting or rewarding; this is known as hyperfocus. The precise causes of<unk>  are unknown in the majority of cases. Genetic factors are estimated to make up about 75% of the risk. Toxins and infections during pregnancy and brain damage may be environmental risks. Despite a popular myth, it does not appear to be related to any particular style of parenting or discipline. It affects about 5–7% of children when diagnosed via the DSM-IV criteria and 1–2% when diagnosed via the ICD-10 criteria. it was estimated to affect 84.7 million people globally. Rates are similar between countries and differences in rates depend mostly on how it is diagnosed.<unk>  is diagnosed approximately twice as often in boys than in girls, although the disorder is overlooked in girls or diagnosed in later life because their symptoms sometimes differ from diagnostic criteria. About 30–50% of people diagnosed in childhood continue to suffer from<unk>  in adulthood, with between 2–5% of all adults being diagnosed with the condition. In adults,<unk>  is usually replaced by inner restlessness, and adults often develop coping skills to compensate for their impairments. The condition can be difficult to tell apart from other conditions, as well as from high levels of activity within the range of normal behavior.<unk>  management recommendations vary by country and usually involve some combination of medications, counseling, and lifestyle changes. The British guideline emphasizes environmental modifications and education for individuals and carers about<unk>  as the first response. If symptoms persist, parent-training, medication, or psychotherapy (especially cognitive behavioral therapy) can be recommended based on age. Canadian and American guidelines recommend medications and behavioral therapy together, except in preschool-aged children for whom the first-line treatment is behavioral therapy alone. Stimulant medications are the most effective pharmaceutical treatment, although there may be side effects and any improvements will be reverted if medication is ceased.<unk> , its diagnosis, and its treatment have been considered controversial since the 1970s. These controversies have involved doctors, teachers, policymakers, parents, and the media. Topics have included causes of<unk>  and the use of stimulant medications in its treatment.<unk>  is now a well-validated clinical diagnosis in children and adults, and the debate in the scientific community mainly centers on how it is diagnosed and treated.<unk>  was officially known as attention<unk>  disorder (ADD) from 1980 to 1987; prior to the 1980s, it was known as hyperkinetic reaction of childhood. Symptoms similar to those of<unk>  have been described in medical literature dating back to the 18th century.
Attention deficit hyperactivity disorder
Conduct disorder
Adult attention deficit hyperactivity disorder
Bipolar disorder
Autism spectrum
Tourette syndrome
Oppositional defiant disorder
Frontal lobe disorder